Literature DB >> 8590983

Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.

C R Hiley1, F E Bottrill, J Warnock, P J Richardson.   

Abstract

1. The receptors mediating the vasodilator responses to adenosine in the isolated mesenteric arterial bed of the rat were identified by use of selective agonists and antagonists and the involvement of the endothelium was examined. 2. Adenosine-mediated dilatation of the mesentery was potentiated by the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 100 microM), but in contrast, removal of the endothelium substantially reduced the responses to adenosine. 3. The order of potency of adenosine receptor agonists was: 5'-N-ethylcarboxamidoadenosine (NECA) > 2-p-(-2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) > 2-chloro-N6-cyclopentyl-adenosine (CCPA) > or = adenosine, suggesting the presence of A2A receptors. 4. Adenosine-mediated dilatation was inhibited by the non-selective adenosine receptor antagonist, 8-phenyltheophylline (3 microM) and by the A2A receptor antagonist 8-(3-chlorostyryl)caffeine (500 nM), but was unaffected by the A1 receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 10 nM). 5. Reducing the pH of the perfusate to 6.8 potentiated the actions of both CGS 21680 and adenosine, but the vasodilator effects of carbachol were the same at both pH values. The adenosine response at the lower pH as at pH 7.4, was unaffected by DPCPX. The actions of the nitrovasodilator, sodium nitroprusside, were also potentiated at pH 6.8 relative to those at the higher pH value but smaller responses were obtained at the lower pH value with forskolin, a stimulator of adenylyl cyclase, than at pH 7.4. 6. It is concluded that the adenosine receptor mediating dilatation of the rat mesenteric arterial bed is of the A2A subtype, that the response, under the conditions used, is apparently partly dependent on the endothelium (but not due to the release of nitric oxide), and that the response to activation of this receptor is potentiated by a reduction in pH which is similar to that seen in ischaemic conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590983      PMCID: PMC1909135          DOI: 10.1111/j.1476-5381.1995.tb17220.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  THE EFFECT OF SYMPATHETIC NERVE STIMULATION OF VASOCONSTRICTOR RESPONSES IN PERFUSED MESENTERIC BLOOD VESSELS OF THE RAT.

Authors:  D D MCGREGOR
Journal:  J Physiol       Date:  1965-03       Impact factor: 5.182

2.  Adenosine, theophylline, and perfusate pH in the isolated, perfused guinea pig heart.

Authors:  G F Merrill; F J Haddy; J M Dabney
Journal:  Circ Res       Date:  1978-02       Impact factor: 17.367

Review 3.  Endothelium-dependent hyperpolarization: a role in the control of vascular tone.

Authors:  C J Garland; F Plane; B K Kemp; T M Cocks
Journal:  Trends Pharmacol Sci       Date:  1995-01       Impact factor: 14.819

4.  Role of histidine residues in the adenosine A2a receptor ligand binding site.

Authors:  R Askalan; P J Richardson
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

5.  Effects of P1 and P2Y purinoceptor antagonists on endothelium-dependent and -independent relaxations of rat mesenteric artery to GTP and guanosine.

Authors:  P Vuorinen; X Wu; P Arvola; H Vapaatalo; I Pörsti
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Role of endothelium in hyperpolarization of coronary smooth muscle by adenosine and its analogues.

Authors:  H A Olanrewaju; P T Hargittai; E A Lieberman; S J Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  1995-02       Impact factor: 3.105

7.  Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.

Authors:  A Monopoli; A Conti; S Dionisotti; C Casati; E Camaioni; G Cristalli; E Ongini
Journal:  Arzneimittelforschung       Date:  1994-12

8.  Characterization of the adenosine receptor in microvascular coronary endothelial cells.

Authors:  J O Schiele; U Schwabe
Journal:  Eur J Pharmacol       Date:  1994-09-15       Impact factor: 4.432

9.  Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.

Authors:  A Rubino; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

10.  Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.

Authors:  B T Liang; B Haltiwanger
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

View more
  11 in total

1.  Acidosis potentiates endothelium-dependent vasorelaxation and gap junction communication in the superior mesenteric artery.

Authors:  Ipsita Mohanty; Subas Chandra Parija; Sujit Suklabaidya; Satish Rattan
Journal:  Eur J Pharmacol       Date:  2018-03-07       Impact factor: 4.432

2.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

3.  Changes in extracellular pH and myocardial ischaemia alter the cardiac effects of diadenosine tetraphosphate and pentaphosphate.

Authors:  B M Stavrou; C Beck; N A Flores
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits.

Authors:  M T Villa de Brito; A Canto; J H Duarte Correia; R A Cunha; M C Marques
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.

Authors:  Bunyen Teng; Daniel Fil; Stephen L Tilley; Catherine Ledent; Thomas Krahn; S Jamal Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

6.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

7.  Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.

Authors:  Scott S Wildman; Robert J Unwin; Brian F King
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

Review 8.  Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.

Authors:  Allan K N Alencar; Guilherme C Montes; Eliezer J Barreiro; Roberto T Sudo; Gisele Zapata-Sudo
Journal:  Front Pharmacol       Date:  2017-12-04       Impact factor: 5.810

9.  Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.

Authors:  Guillaume Lebon; Patricia C Edwards; Andrew G W Leslie; Christopher G Tate
Journal:  Mol Pharmacol       Date:  2015-03-11       Impact factor: 4.436

10.  Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction.

Authors:  M Verónica Donoso; M Jesús Mascayano; Inés M Poblete; J Pablo Huidobro-Toro
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.